Abatini Carlo, Barberis Lorenzo, Lodoli Claudio, Ferracci Federica, De Lorenzis Enrico, D'Annibale Giorgio, Aulicino Matteo, Quirino Michela, Di Salvatore Mariantonietta, Alfieri Sergio, Pacelli Fabio, Santullo Francesco
Surgical Unit of Peritoneum and Retroperitoneum Surgery, Fondazione Policlinico Universitario Agostino, Gemelli IRCCS, 00168 Rome, Italy.
General Surgery Department, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Cancers (Basel). 2025 May 27;17(11):1787. doi: 10.3390/cancers17111787.
RPS are rare tumors requiring complex surgery. The impact of postoperative complications on long-term outcomes is still debated. This study aimed to identify predictors of severe complications and assess their influence on overall survival (OS) and disease-free survival (DFS).
We retrospectively analyzed 61 patients who underwent curative surgery for primary RPS between 2013 and 2023 at a tertiary cancer center. Patients with pelvic or recurrent sarcomas were excluded. Severe complications were defined as Clavien-Dindo (CD) grade ≥ 3A. Cox regression and Fine-Gray competing risk models were used for OS and DFS, respectively. Sarculator and P-POSSUM scores were included in multivariable models.
Severe complications occurred in 14.8% of patients; 30-day mortality was 1.6%. Predictive factors for complications included longer operative time, gastric resection, intraoperative complications, and transfusions. In multivariable analysis, Sarculator was significantly associated with both DFS (HR 0.97; = 0.004) and OS (HR 0.97; = 0.008). The P-POSSUM mortality score predicted OS (HR 1.12; = 0.002). Severe complications were not independently associated with DFS or OS.
In this cohort, severe complications did not impact long-term oncological outcomes. Prognostic tools such as Sarculator and P-POSSUM may enhance risk stratification in RPS surgery. Prospective validation is warranted.
腹膜后肉瘤(RPS)是罕见肿瘤,需要进行复杂手术。术后并发症对长期预后的影响仍存在争议。本研究旨在确定严重并发症的预测因素,并评估其对总生存期(OS)和无病生存期(DFS)的影响。
我们回顾性分析了2013年至2023年在一家三级癌症中心接受原发性RPS根治性手术的61例患者。排除盆腔或复发性肉瘤患者。严重并发症定义为Clavien-Dindo(CD)分级≥3A。Cox回归模型和Fine-Gray竞争风险模型分别用于分析总生存期和无病生存期。多变量模型纳入了Sarculator评分和P-POSSUM评分。
14.8%的患者发生了严重并发症;30天死亡率为1.6%。并发症的预测因素包括手术时间延长、胃切除术、术中并发症和输血。在多变量分析中,Sarculator评分与无病生存期(风险比[HR]0.97;P = 0.004)和总生存期(HR 0.97;P = 0.008)均显著相关。P-POSSUM死亡评分可预测总生存期(HR 1.12;P = 0.002)。严重并发症与无病生存期或总生存期无独立相关性。
在该队列中,严重并发症并未影响长期肿瘤学预后。Sarculator和P-POSSUM等预后工具可能会改善腹膜后肉瘤手术的风险分层。有必要进行前瞻性验证。